AMBER DALE: Open Payments
NPI 1831695170 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 9 payments from 4 companies in 2025. Trend: 2023 $203 · 2024 $116 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $178 |
| Neurocrine BioSciences, Inc. | 2 | $160 |
| Lundbeck LLC | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: ABILIFY MAINTENA, INGREZZA, INVEGA SUSTENNA.
Industry payments across GA — which companies pay providers there.
